Home - CLL Global Research Foundation
Acceletarting Resaerch - Changing the Course of CLL

Our mission is to abolish chronic lymphocytic leukemia (CLL) as a threat to the life and health of patients by accelerating CLL research.

Advice from the experts:

Learn more about new therapies:
The Evolving Story of ABT-199

Advice from experts The Evolving Story of ABT-199

CLL Global Research Foundation began as a concept from patients with chronic lymphocytic leukemia (CLL) and their families. Read the full story here. pdf

Since 2004 we have funded over $17 million to researchers all over the world who are making headway in the advancement of CLL research. Thanks to the generosity of our supporters, great strides have been made to eliminate CLL.

Together, we are solving the CLL research puzzle.

CLL research puzzle CLL news Grant Recipients Research Success Get Involved



Join Our Mailing List

Join Our Group on Facebook

Dr. Michael Keating

Dr. Michael Keating

Featured Article:
Say Goodbye to CLL pdf icon

Welcome Message:
Welcome to the CLL Global Research Foundation web site. Our goal is to eliminate chronic lymphocytic leukemia (CLL) as a threat to life by funding outstanding research aimed at eradicating this disease. Read more.

Dr. Michael Keating, professor of medicine at MD Anderson Cancer Center, serves as president and CEO of the CLL Global Research Foundation. He is an internationally renowned CLL clinical scientist dedicated to patient care and to development of potentially curative CLL therapies.

© 2015 CLL Global Research Foundation • P.O. Box 301402, Unit 428 • Houston, TX 77230

Home - CLL Global Research Foundation